Invasive Haemophilus influenzae type b infections in vaccinated and unvaccinated children in Canada, 2001-2003

CMAJ. Canadian Medical Association Journal

Volumn 172, Issue 1, 2005, Pages 53-56

  Scheifele, David ^a   Halperin, Scott ^b   Law, Barbara ^c   King, Arlene ^d  

^a BC CHILDREN S HOSPITAL   (Canada)

^b IWK HEALTH CENTRE   (Canada)

^c CHILDREN S HOSPITAL RESEARCH INSTITUTE OF MANITOBA   (Canada)

^d HEALTH CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

AGE DISTRIBUTION; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE PREDISPOSITION; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HOSPITAL ADMISSION; HOSPITAL INFORMATION SYSTEM; HUMAN; IMMUNE DEFICIENCY; INFECTION COMPLICATION; INFLUENZA; INFLUENZA VACCINATION; INFORMATION RETRIEVAL; MALE; MEDICAL RECORD; TREATMENT REFUSAL;

EID: 12344325093     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.1031861     Document Type: Article

References (15)

1. Haemophilus influenzae infection in Canada, 1969-85. Can Dis Wkly Rep 1986;12:37-43.
2. Scheifele DW, Halperin SA; CPS/Health Canada Immunization Monitoring Program, Active (IMPACT). Immunization Monitoring Program, Active: a model of active surveillance of vaccine safety. Semin Pediatr Infect Dis 2003;14:213-9.
3. Scheifele DW. Recent trends in pediatric Haemophilus influenzae type b infections in Canada. Immunization Monitoring Program, Active (IMPACT) of the Canadian Paediatric Society and the Laboratory Centre for Disease Control. CMAJ 1996;154(7):1041-7.
4. Haemophilus influenzae type b disease at 11 pediatric centres, 1996-1997 [published erratum in Can Commun Dis Rep 1998;24(18):151]. Can Commun Dis Rep 1998;24(13):105-8.
5. Haemophilus influenzae type b disease control using Pentacel, Canada, 1998-1999. Can Commun Dis Rep 2000;26(11):93-6.
6. Historic low Haemophilus influenzae type b case tally - Canada 2000. Can Commun Dis Rep 2001;27(18):149-50.
7. McVernon J, Andrews N, Slack MPE, Ramsay ME. Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. Lancet 2003;361:1521-3.
8. Dagan R, Eskola J, Leclerc C, Leroy O. Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect Immun 1998;66:2093-8.
9. Notifiable diseases annual summary - 2000. Can Commun Dis Rep 2003;29 (Suppl 2):20-2.
10. Measuring up: results from the National Immunization Coverage Survey, 2002. Can Commun Dis Rep 2004;30(5):37-50.
11. Hviid A, Melbye M. Impact of routine vaccination with a conjugate Haemophilus influenzae type b vaccine. Vaccine 2004;22:378-82.
12. Ward JI, Margolis HS, Lum MKW, Fraser DW, Bender TR, Anderson P. Haemophilus influenzae disease in Alaskan Eskimos: characteristics of a population with an unusual incidence of invasive disease. Lancet 1981;1:1281-5.
13. Galil K, Singleton R, Levine OS, Fitzgerald MA, Bulkow L, Getty M, et al. Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. J Infect Dis 1999;179(1):101-6.
14. Singleton R, Bulkow LR, Levine OS, Butler JC, Hennessy TW, Parkinson A. Experience with the prevention of invasive Haemophilus influenzae type b disease by vaccination in Alaska: the impact of persistent oropharyngeal carriage. J Pediatr 2000;137(3):313-20.
15. Makela PH, Kayhty H, Leino T, Auranen K, Peltola H, Ekstrom N, et al. Long-term persistence of immunity after immunisation with Haemophilus influenzae type b conjugate vaccine. Vaccine 2003;22:287-92.